Skip to main navigation Skip to search Skip to main content

Lebrikizumab Provides Rapid Clinical Responses Across All Eczema Area and Severity Index Body Regions and Clinical Signs in Adolescents and Adults with Moderate-to-Severe Atopic Dermatitis

  • Eric L. Simpson
  • , Marjolein de Bruin-Weller
  • , H. Chih ho Hong
  • , Delphine Staumont-Sallé
  • , Andrew Blauvelt
  • , Kilian Eyerich
  • , Melinda Gooderham
  • , Mona Shahriari
  • , Lotus Mallbris
  • , Amber Reck Atwater
  • , Maria Jose Rueda
  • , Yuxin Ding
  • , Zhuqing Liu
  • , Helena Agell
  • , Jonathan I. Silverberg
  • Oregon Health and Science University
  • University Medical Center Utrecht
  • University of British Columbia
  • University of Lille
  • Oregon Medical Research Center
  • Albert-Ludwigs-Universität Freiburg
  • SKiN Centre for Dermatology
  • Yale University Medical School
  • Lilly Corporate Center
  • Almirall, S.A
  • George Washington School of Medicine and Health Sciences

Research output: Contribution to journal › Article › peer-review

15 Scopus citations

Fingerprint

Dive into the research topics of 'Lebrikizumab Provides Rapid Clinical Responses Across All Eczema Area and Severity Index Body Regions and Clinical Signs in Adolescents and Adults with Moderate-to-Severe Atopic Dermatitis'. Together they form a unique fingerprint.
Sort by

Keyphrases

Nursing and Health Professions

Immunology and Microbiology